Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

NCT00456417 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Alzheimers Disease

Interventions

DRUG: 123-I MNI-187 Injection and Imaging Procedures

Sponsor

Institute for Neurodegenerative Disorders

Collaborators

[object Object]